Associations between obesity and severity of coronavirus disease 2019 in Brazilian inpatients: A 2021 secondary data analysis
Authors:
- Gabrielle Ribeiro SenaGSGabrielle Ribeiro Sena
- Tiago Pessoa Ferreira de LimaTLTiago Pessoa Ferreira de Lima
- Michelle Lima de Carvalho SilvaMSMichelle Lima de Carvalho Silva
- Gabriela Carla dos Santos CostaGCGabriela Carla dos Santos Costa
- Maria Júlia Gonçalves de MelloMMMaria Júlia Gonçalves de Mello
- Guilherme Jorge CostaGCGuilherme Jorge Costa
- 9 August 2024
- journal article
- research article
- Published by Wiley in Clinical Obesity
- Vol. 14 (6) , e12698
Abstract
Summary: In the backdrop of the global obesity pandemic, recognized as a notable risk factor for coronavirus disease 2019 (COVID‐19) complications, the study aims to explore clinical and epidemiological attributes of hospitalized COVID‐19 patients throughout 2021 in Brazil. Focused on four distinct age cohorts, the investigation scrutinizes parameters such as intensive care unit (ICU) admission frequency, invasive mechanical ventilation (IMV) usage, and in‐hospital mortality among individuals with and without obesity. Using a comprehensive cross‐sectional study methodology, encompassing adult COVID‐19 cases, data sourced from the Influenza Epidemiological Surveillance Information System comprises 329 206 hospitalized patients. Of these individuals, 26.3% were affected by obesity. Analysis reveals elevated rates of ICU admissions, increased dependence on IMV, and heightened in‐hospital mortality among the individuals with obesity across all age groups (p < .001). Logistic regression, adjusting for confounding variables, underscores a progressively rising odds ratio for mortality in younger age brackets: 1.2 (95%CI 1.1–1.3) for those under 50 years, 1.1 (95%CI 1.0–1.2) for the 50–59 age group, and 1.1 (95%CI 1.0–1.2) for the 60–69 age group. Conversely, no significant mortality difference is observed for patients over 70 years (OR: 0.972, 95%CI 0.9–1.1). In summary, hospitalized COVID‐19 patients with obesity, particularly in younger age groups, exhibit elevated rates of ICU admission, IMV requirement, and in‐hospital mortality compared with the control group. Notably, the ‘obesity paradox’ is not evident among hospitalized COVID‐19 patients in 2021.Keywords
This publication has 15 references indexed in Scilit:
- A potential association between obesity and reduced effectiveness of COVID‐19 vaccine‐induced neutralizing humoral immunityJournal of Medical Virology, 2022
- Why should obese youth be prioritized in COVID-19 vaccination programs? A nationwide retrospective studyThe Lancet Regional Health - Americas, 2022
- BMI and pneumonia outcomes in critically ill COVID‐19 patients: An international multicenter studyObesity, 2021
- Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registryObesity Research & Clinical Practice, 2021
- Body Mass Index and 90-Day Mortality Among 35,406 Danish Patients Hospitalized for InfectionMayo Clinic Proceedings, 2021
- The Obesity Paradox in Infections and Implications for COVID-19Mayo Clinic Proceedings, 2021
- The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohortNutrition, Metabolism and Cardiovascular Diseases, 2020
- Severe Obesity as an Independent Risk Factor for COVID‐19 Mortality in Hospitalized Patients Younger than 50Obesity, 2020
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseNew England Journal of Medicine, 2017
- Body mass index and mortality in heart failure: A meta-analysisAmerican Heart Journal, 2008